Advertisement
Gastrointestinal symptoms are common in patients with coronavirus disease 2019

Gastrointestinal Symptoms Common in COVID-19 Patients

0
GI symptoms were more prevalent in later stages of epidemic in China
Certain patient and presentation factors increase the likelihood of a missed appendicitis diagnosis in the emergency department

Risk Factors for Missed Appendicitis Diagnosis Identified

0
6 percent of adults and 4.4 percent of children misdiagnosed during initial emergency department visit
Proton pump inhibitors taken for acid reflux may lead to an increased risk for fractures in children and adolescents

Proton Pump Inhibitor Therapy May Up Fracture Risk in Children

0
Fracture risk remained higher after adjusting for differences in sex, race, other factors
Endoscopy within six hours versus six to 24 hours after consultation is not associated with lower 30-day mortality in patients with acute upper gastrointestinal bleeding who are at high risk for further bleeding or death

Endoscopy Within Six Hours Does Not Lower Mortality in GI Bleed

0
30-day mortality did not differ for those undergoing endoscopy within six hours versus six to 24 hours
From 2011 to 2017

Burden of Clostridioides difficile Infection Down in the U.S.

0
Decrease seen in adjusted estimate of national burden of health care-associated C. difficile infection
Following implementation of the Affordable Care Act

Unemployed Workers Less Likely to Be Uninsured Post-ACA

0
Following implementation of ACA, insurance rates decreased more in states with Medicaid expansion
Hospitalizations for chronic liver disease increased from 2012 to 2016

Hospitalizations for Chronic Liver Disease on the Rise

0
Burden due to alcoholic cirrhosis and nonalcoholic fatty liver disease also increased
Patients with mild coronavirus disease 2019 can present with digestive symptoms

Patients With Mild COVID-19 May Present With Digestive Symptoms

0
Many with digestive symptoms present with diarrhea; 62.4 percent with digestive symptoms have fever

March 2020 Briefing – Gastroenterology

0
Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for March 2020. This roundup includes the latest...
All versions of the heartburn drug Zantac (ranitidine) have been pulled from the U.S. market due to possible contamination with a probable human carcinogen

FDA Pulls Heartburn Drug Zantac From Market

0
Withdrawal of ranitidine products means they will not be available either by prescription or OTC